Company DescriptionCore One Labs Inc. operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents. The company also offers consulting, financing, and micro cultivation services, as well as operates medical and wellness clinics. In addition, it provides natural health products; and news dissemination services. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

How the Company Makes Money

Core One Labs Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

TTM	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Breakdown
Income Statement		Total Revenue
198.71K	458.54K	431.62K	0.00	5.04M	4.08M
	Gross Profit
237.54K	416.34K	392.85K	0.00	-669.57K	-1.69M
	EBIT
-5.10M	-7.84M	-12.17M	-6.52M	-15.34M	-11.92M
	EBITDA
-14.42M	-15.94M	-36.99M	-4.59M	-7.29M	-12.97M
	Net Income Common Stockholders
-14.44M	-15.98M	-37.11M	-55.25M	-22.04M	-12.29M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
411.85K	736.48K	873.35K	1.90M	411.85K	993.53K
	Total Assets
17.80M	8.11M	7.61M	9.52M	17.80M	21.06M
	Total Debt
4.37M	280.00K	30.00K	427.76K	4.37M	721.00K
	Net Debt
4.25M	-346.48K	-733.35K	-100.61K	4.25M	268.70K
	Total Liabilities
12.18M	1.40M	3.30M	4.13M	12.18M	4.78M
	Stockholders Equity
7.23M	6.72M	4.31M	5.39M	7.23M	17.78M
Cash Flow		Free Cash Flow
-1.55M	-2.01M	-4.65M	-2.32M	-7.41M	-16.84M
	Operating Cash Flow
-1.53M	-2.00M	-4.64M	-2.32M	-5.77M	-10.16M
	Investing Cash Flow
38.63K	228.96K	1.29M	-314.89K	-18.59K	-6.68M
	Financing Cash Flow
-31.78K	2.40M	3.58M	4.43M	5.45M	14.40M

Core One Labs Peers Comparison

Overall Rating

UnderperformOutperform

Sector (54)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COOL		C$6.83M	―		―	―	―
Sector *	54 Neutral	$5.31B	3.28	-45.10%	2.80%	16.76%	0.02%
QPT		C$7.61M	―	-8.09%	―	―	―
BVAXF		$8.52M	―		―	―	―
GLOW	41 Neutral	C$9.35M	―	-247.04%	―	2733.38%	34.80%
RKV		C$5.21M	―	-203.41%	―	―	―
IBO		C$5.50M	―	-216.76%	―	―	―

* Healthcare Sector Average

Performance Comparison

TSE:COOL

Core One Labs

0.14

-0.03

-17.65%

TSE:QPT

Quest Pharmatech

0.06

0.03

100.00%

BVAXF

BioVaxys Technology

0.03

-0.02

-40.00%

TSE:GLOW

Glow LifeTech

0.06

0.03

100.00%

TSE:RKV

Rakovina Therapeutics Inc

0.05

-0.05

-50.00%

TSE:IBO

Universal Ibogaine Inc

0.02

0.00

0.00%

Glossary

OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.

NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.

UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.